Advisory Board and Editors HIV

Zandrea Ambrose

Assistant Professor in the Division of Infectious Diseases, Department of Medicine and Graduate Program in Molecular Virology and Microbiology, University of Pittsburgh School of Medicine. Co-Director of the Imaging Core of the Pittsburgh Center for HIV Protein Interactions.

Stefan D Baral

Stefan Baral is a physician epidemiologist and an Associate Professor in the Department of Epidemiology at the Johns Hopkins School of Public Health (JHSPH). Stefan has led epidemiological studies among key populations including men who have sex with men and sex workers in Southern, Eastern, and Western African countries as well as in Central and Southeastern Asia. Stefan acts as the Director of the Key Populations Program for the Center for Public Health and Human Rights at the JHSPH.

Keith A Crandall

Founding Director of the Computational Biology Institute at George Washington University. Past Chair of the Department of Biology at Brigham Young University. PhD in Biology and Biomedical Sciences from Washington University in St. Louis.

Barbara Ensoli

Director of the National AIDS Center, Istituto Superiore di Sanità, Rome, Italy. Co-Vice President and Member of the Presidential Committee of the AIDS National Commission, Ministry of Health. Member of the European Molecular Biology Organisation (EMBO).

Shou-Jiang (SJ) Gao

Professor of Molecular Microbiology and immunology at Keck School of Medicine, University of Southern California.

Delia Goletti

Delia Goletti MD, PhD, Infectious Diseases specialist. In 1992 she joined the Laboratory of Immunoregulation at the National Institutes of Health (chief Dr Fauci) working on HIV pathogenesis. In 1999 she joined the National Institute for Infectious Diseases in Rome. She has clinical duties on the tuberculosis (TB) clinic and responsibility of the Translational Research Unit where she works on TB pathogenesis, TB immunodiagnostic tests and impact of Heminths infection on HIV and TB disease.

Bill Hooker

PhD = cloning and characterizing potential vaccine antigens from schistosomes; first postdoc = fine details of HIV replication (with David Harrich); second postdoc = best ignored; third postdoc = role of Max network, especially Mnt, in cancer and development (with Peter Hurlin). Now I make HIV and other diagnostic devices in a small biotech company.

Alessandra Lo Presti

Expert in molecular epidemiology and phylogeny of infectious disease. Principal investigator of the Project “Cross Sectional study to evaluate the interactions between gut microflora and immune system at the cross-road of the pathogenesis of Inflammatory Bowel Diseases and Irritable Bowel Sydrome.”

George N. Pavlakis

MD, U. of Athens, Greece
PhD, Syracuse U, NY
Chief of the Human Retrovirus Section of the National Cancer Institute, USA
Interests: HIV pathogenesis, Molecular Biology, gene regulation, Biotechnology, protein engineering, cytokines, Immunotherapy, Vaccines, Nucleic acid vaccines, gene therapy

Pleuni S Pennings

I am an evolutionary biologist and work on the evolution of drug resistance in HIV. I want to understand what determines the rate of evolution of drug resistance, so that we can find ways to halt the evolution of drug resistance.

Before switching to HIV, I worked on ants, sympatric speciation and soft sweeps. I also write and tweet and make video’s.

If you have questions or would like to discuss an idea, feel free to drop me a line (pennings at!

Steffanie A. Strathdee

Associate Dean of Global Health Sciences, Harold Simon Professor and Chief of the Division of Global Public Health in the Department of Medicine at the University of California San Diego School of Medicine. She is an infectious disease epidemiologist with expertise in HIV and STD prevention interventions. In 2009, she and her team were awarded the Leadership Award in International Collaboration from the National Institute on Drug Abuse (NIDA). She also holds a MERIT award from NIDA.

Ravi Tandon

I completed my Ph.D dissertation at the University of Zurich, Switzerland where major focus of my PhD research project was the study of endogenous feline leukemia virus (enFeLV) in cats during exogenous feline leukemia virus (FeLV) infection. My interest in retroviruses led me into the HIV research after Ph.D. My postdoctoral research project at University of California, San Francisco was on HIV immunology. On completion of my Post Doc, I joined Dr Ndhlovu’s new laboratory at the University of Hawaii to pursue studies on HIV and Aging based on my expertise and experience to address a new area of HIV research in which have interest.

Currently my research work as an Assistant Professor at JNU, New Delhi, India is focused on aging in HIV-1-infected people. Approximately one in five individuals living with HIV infection in the United States is 50 years of age or older. This proportion continues to increase as HIV incidence remains stable and potent antiretroviral therapy has reduced the morbidity and mortality associated with HIV infection. However, premature aging and non-AIDS related morbidity including cancer seem to be a new big problem in HAART era. Chronic inflammation in treated HIV-1-infected subjects seems to play an important role in non-AIDS –related complications. The main goal of my research is to investigate the mechanism of HIV mediated accelerated aging/inflammation in HAART-suppressed HIV-1 infected people.

It's Free. Enter your email or learn more.

Peer-reviewed articles in this subject area

PrePrints in this subject area